These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 1554951)
1. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report. Safferman AZ; Masiar SJ Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951 [TBL] [Abstract][Full Text] [Related]
2. MAOIs in the contemporary treatment of depression. Thase ME; Trivedi MH; Rush AJ Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154 [TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitors revisited: what you should know. Goldberg JF; Thase ME J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352 [No Abstract] [Full Text] [Related]
10. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307 [TBL] [Abstract][Full Text] [Related]
11. Tricyclic antidepressants and monoamine oxidase inhibitors. Schuckit M; Robins E; Feighner J Arch Gen Psychiatry; 1971 Jun; 24(6):509-14. PubMed ID: 5578096 [No Abstract] [Full Text] [Related]
12. Stroke resulting from a rapid switch from phenelzine to tranylcypromine. Mattes JA J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269 [No Abstract] [Full Text] [Related]
13. Severe daytime somnolence in patients treated with an MAOI. Teicher MH; Cohen BM; Baldessarini RJ; Cole JO Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886 [TBL] [Abstract][Full Text] [Related]
14. Three cases of female anorgasmia associated with MAOIs. Lesko LM; Stotland NL; Segraves RT Am J Psychiatry; 1982 Oct; 139(10):1353-4. PubMed ID: 7124995 [TBL] [Abstract][Full Text] [Related]
15. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors. Kahn D; Silver JM; Opler LA J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181 [TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with phenelzine and other irreversible monoamine oxidase inhibitors downregulates I2-imidazoline receptors in the brain and liver. Alemany R; Olmos G; García-Sevilla JA Ann N Y Acad Sci; 1995 Jul; 763():506-9. PubMed ID: 7677366 [No Abstract] [Full Text] [Related]